Literature DB >> 22429357

Comparison of the optimal effect-site concentrations of remifentanil for preventing cough during emergence from desflurane or sevoflurane anaesthesia.

H B Cho1, J Y Kim, D H Kim, D W Kim, Y J Chae.   

Abstract

OBJECTIVE: To compare the effect-site concentrations of remifentanil target-controlled infusion (TCI) that produced 50% and 95% of the maximal effect (EC50 and EC95, respectively) for preventing cough during emergence from desflurane or sevoflurane anaesthesia, in patients undergoing elective thyroidectomy.
METHODS: Adults undergoing elective thyroidectomy were randomized to receive anaesthesia with desflurane or sevoflurane. The EC50 and EC95 values for remifentanil TCI were determined using Dixon's up-and-down method and probit analysis with sigmoid curve.
RESULTS: In total, 48 patients aged 20-64 years were enrolled in the study. The EC50±SD of remifentanil TCI, determined by Dixon's up-and-down method, were 1.54±0.70 and 1.11±0.24 ng/ml for desflurane and sevoflurane, respectively. The EC95 of remifentanil TCI, analysed by probit analysis, were 2.88 ng/ml and 2.29 ng/ml for desflurane and sevoflurane, respectively. The effect-site concentration of remifentanil TCI for preventing cough during emergence from desflurane anaesthesia was not significantly higher than that observed for sevoflurane.
CONCLUSIONS: During emergence from anaesthesia, variations in effect-site concentrations of remifentanil for preventing cough are of limited importance as they do not generate significant differences in results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429357     DOI: 10.1177/147323001204000118

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

1.  Risk factors of cough in non-small cell lung cancer patients after video-assisted thoracoscopic surgery.

Authors:  Rongjia Lin; Guowei Che
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Predicted EC₅₀ and EC₉₅ of Remifentanil for Smooth Removal of a Laryngeal Mask Airway Under Propofol Anesthesia.

Authors:  Ji Young Yoo; Hyun Jeong Kwak; Kyung Cheon Lee; Go Wun Kim; Jong Yeop Kim
Journal:  Yonsei Med J       Date:  2015-07       Impact factor: 2.759

3.  Effect of neuromuscular blockade reversal by pyridostigmine on spectral entropy values during recovery from desflurane anesthesia: a prospective, randomized, double-blind, controlled trial.

Authors:  Eugene Kim; Jae Hun Ryu; Sung Hye Byun
Journal:  Korean J Anesthesiol       Date:  2016-06-01

4.  Effects of age on effect-site concentration of remifentanil for suppressing anesthetic emergence cough in male patients undergoing laparoscopic cholecystectomy.

Authors:  Ha Yeon Kim; Sook Young Lee; Seyoon Kang; Bora Kim; Yeo Rae Moon; Ji Eun Kim
Journal:  Clin Interv Aging       Date:  2018-05-30       Impact factor: 4.458

5.  Comparison of sevoflurane and desflurane on effect-site concentration of remifentanil for preventing anesthetic emergence cough in elderly female patients undergoing laparoscopic cholecystectomy.

Authors:  Ha Yeon Kim; Yeo Rae Moon; Suhyun Seok; Bora Kim; Ji Eun Kim; Sook Young Lee
Journal:  Clin Interv Aging       Date:  2018-09-13       Impact factor: 4.458

6.  A small dose of remifentanil pretreatment suppresses sufentanil-induced cough during general anesthesia induction: a randomized, double-blind, placebo-controlled trial.

Authors:  Wendong Lin; Jiehao Sun; Shuying Fu
Journal:  BMC Anesthesiol       Date:  2019-08-28       Impact factor: 2.217

7.  Effects of smoking on the optimal effect-site concentration of remifentanil required for preventing cough during anesthetic emergence in male patients undergoing laparoscopic or robotic cholecystectomy.

Authors:  Ha Yeon Kim; Jong Bum Choi; Eunyoung A Lee; Sei Hyuk Kwon; Ji Eun Kim; Sook Young Lee
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

8.  Sex-related differences in effect-site concentration of remifentanil for preventing anesthetic emergence cough in elderly patients.

Authors:  Sook Young Lee; Yun Yong Jeong; Byung Ho Lee; Ji Eun Kim
Journal:  Clin Interv Aging       Date:  2018-01-05       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.